Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes

Research using a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis. The study, published by Cell Press in the November issue of the journal Cancer Cell, also validates examination of histone modification as a strategy for distinguishing cancer subtypes.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144947285.html">Mouse model highlights histone methylation as distinguishing feature for leukemia subtypes</a></p> <p>Research using a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis. The study, published by Cell Press in the November issue of the journal <I>Cancer Cell</I>, also validates examination of histone modification as a strategy for distinguishing cancer subtypes.</p>